Market closed·Syncing…
Market closed · Close · 19 Nov

Nephrocare Health Services Limited NEPHROPLUSshare price and chart

Nephrocare Health Services closed at ₹641.95 on 19 November 2026, down 1.69% on the day. The 52-week range is ₹446.00 to ₹781.50.

₹641.95The price one share last traded at, in rupees.▼ 1.69% · ₹11.04
52-wk low ₹44658% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹782

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on NEPHROPLUS

Real prices, every charge counted. Pick one or write your own.

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
52Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
48.1%Near average
today 48.1%20d avg 48.2%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 2.2%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.+2.4%1 monthHow much the share price has changed over the period.+5.4%3 monthsHow much the share price has changed over the period.▼ 7.1%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.31.1%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹6,455 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.49.4xlast 4 quarters, to Sept 2026Return on equityHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.6.9%full year FY26Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.5.43xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.13.4%full year FY26EV / EBITDAWhat it would cost to buy the whole company, against the cash profit its business makes in a year. It is a P/E that ignores how the company is financed.24.3xDividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.07xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.11.4%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Healthcare Service Provider · 15 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.49.42vs 34.87 median
Cheapest: ONEGLOBAL 11.99Priciest: VIJAYA 76.29
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.11.54%vs 14.05% median
Lowest: HEALTHX -1.41%Highest: 3BBLACKBIO 35.36%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 3 Nov 2026), sales was ₹303 cr and profit was ₹33.5 cr.

Worth watching
  • Promoter holding fell 5.5 points over 3 quarters (63.85% to 58.31%).
Also changed
  • Foreign institutions raised their holding by 8.1 points over 3 quarters (3.59% to 11.73%).

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Share price reaction to resultsWhat the share price did around each recent quarterly result.

Over the last 4 results, the share rose on 1 and fell on 3, and moved by 3% or more on 2.

+10%
-10%
Q4 FY26Q2 FY27

Q2 FY27: results filed 3 Nov 2026. The share went from its close on 2 Nov 2026 to its close on 4 Nov 2026 -0.31%.

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
58.31%promoter holding, as of 2026-09-30-5.5 pts since 2025
Promoter share since listing
2025-1258.31% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
58.3%
21.8%
Promoter58.3%Foreign (FII)11.7%Domestic (DII)8.1%Public & others21.8%
Who is buying, who is leavingDec 25 to Sep 26
Promoter58.3%-5.5 pts
Foreign (FII)11.7%+8.1 pts
Domestic (DII)8.1%-0.6 pts

Each line is that holder's share of all shares over the last 5 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Options to purchase securities17-Nov-2026

Nephrocare Health Services Limited has informed the Exchange about Options to purchase securities

ESOP/ESOS/ESPS17-Nov-2026

Nephrocare Health Services Limited has informed the Exchange regarding of 342130 Options.

Analysts/Institutional Investor Meet/Con. Call Updates12-Nov-2026

Nephrocare Health Services Limited has informed the Exchange about Transcript

Analysts/Institutional Investor Meet/Con. Call Updates12-Nov-2026

Nephrocare Health Services Limited has informed the Exchange about Schedule of meet

Analysts/Institutional Investor Meet/Con. Call Updates04-Nov-2026

Nephrocare Health Services Limited has informed the Exchange about Link of Recording

Monitoring Agency Report03-Nov-2026

Pursuant to Reg 32 of SEBI LODR Regulations, 2015 read with Reg 41 of SEBI ICDR Regulations, 2018, please find enclosed Monitoring Agency Report for the quarter ended September 30, 2026.

Investor Presentation03-Nov-2026

Nephrocare Health Services Limited has informed the Exchange about Investor Presentation

Press Release03-Nov-2026

Nephrocare Health Services Limited has informed the Exchange regarding a press release dated November 03, 2026, titled "Nephrocare Health Services Limited, Asia s largest dialysisnetwork under the brand NephroPlus announced its Financial Results for second quarterand half year ended 30th September 2026.".

Outcome of Board Meeting03-Nov-2026

Nephrocare Health Services Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company02-Nov-2026

Nephrocare Health Services Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

Agreements27-Oct-2026

Nephrocare Health Services Limited has informed the Exchange about Agreements

Analysts/Institutional Investor Meet/Con. Call Updates21-Oct-2026

Nephrocare Health Services Limited has informed the Exchange about Schedule of meet

Certificate under SEBI (Depositories and Participants) Regulations, 201807-Oct-2026

Nephrocare Health Services Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Trading Window25-Sep-2026

Nephrocare Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Analysts/Institutional Investor Meet/Con. Call Updates22-Sep-2026

Nephrocare Health Services Limited has informed the Exchange about Schedule of meet

Backtest idea · NEPHROPLUSMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on NEPHROPLUS
Backtest idea · NEPHROPLUSLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on NEPHROPLUS
Backtest idea · NEPHROPLUSSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on NEPHROPLUS
Your own ideaWrite a rule for NEPHROPLUS in plain English“Buy NEPHROPLUS when …”
Start writing
Buy the dip on NEPHROPLUSBuy when RSI(14) drops below 30
52-week high breakout on NEPHROPLUSBuy when closes at a 52-week high
Golden cross on NEPHROPLUSBuy when 50-day EMA crosses above 200-day
Stochastic oversold on NEPHROPLUSBuy when stochastic %K drops below 20
Pullback in an uptrend on NEPHROPLUSBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹6,455 cr
Larger than 73% of 15 peers
sector middle ₹867 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
49.4x
Higher than 60% of 10 peers
sector middle 34.9x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
5.4x
Around the middle of 13 peers
sector middle 4.4x
ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.
6.9%
Lower than 88% of 8 peers
sector middle 14.9%
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
13.4%
Lower than 78% of 9 peers
sector middle 22.4%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.07
Higher than 62% of 13 peers
sector middle 0.03
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 53% of 15 peers
sector middle 0.1%

Peers are the listed companies in the exchange's own industry group: Healthcare Service Provider. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹2 Cr, after ₹119 Cr spent on plant and equipment.

FY26Cash in or out
Running the business+₹233 Cr
Investing-₹410 Cr
Lenders and shareholders+₹157 Cr
Net change in cash-₹2 Cr

The full numbersSales and net profit by financial year or by quarter.

Backtest idea · NEPHROPLUSStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on NEPHROPLUS
Backtest idea · NEPHROPLUSPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on NEPHROPLUS
Backtest idea · NEPHROPLUSBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on NEPHROPLUS
Backtest idea · NEPHROPLUS52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on NEPHROPLUS
Backtest idea · NEPHROPLUSGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on NEPHROPLUS
MACD momentum on NEPHROPLUSBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on NEPHROPLUSBuy when closes below the lower Bollinger band
Supertrend rider on NEPHROPLUSBuy when supertrend turns up
Buy the dip on NEPHROPLUSBuy when RSI(14) drops below 30
52-week high breakout on NEPHROPLUSBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Healthcare Service Provider
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
LALPATHLAB
Dr. Lal Path Labs Ltd.
32,952 cr56.2x12.0x21.5%29.1%0.0019.4%+19.6%0.89%
VIJAYA
Vijaya Diagnostic Centre Limited
15,559 cr76.3x14.7x19.7%30.3%0.0022.4%+26.7%0.13%
METROPOLIS
Metropolis Healthcare Limited
11,587 cr51.6x7.1x13.4%19.6%0.0112.7%+15.8%0.36%
THYROCARE
Thyrocare Technologies Limited
8,035 cr56.1x14.5x28.7%37.8%0.0015.4%+25.1%1.39%
NEPHROPLUS
Nephrocare Health Services Limited
6,455 cr49.4x5.4x6.9%13.4%0.0711.5%-0.00%
SURAKSHA
Suraksha Diagnostic Limited
1,718 cr41.1x6.2x13.8%24.8%0.0211.9%+25.8%0.15%
KRSNAA
Krsnaa Diagnostics Limited
1,673 cr17.0x1.6x10.9%12.7%0.5711.1%+31.5%0.39%
3BBLACKBIO
3B Blackbio Dx Limited
1,130 cr19.1x----35.4%+42.4%0.38%
HEALTHX
Health X Platform Limited
867 cr-1.4x-0.2%-0.04-1.4%+60.7%0.00%
CREDENT
Credent Connect N Care Limited
860 cr-6.1x--0.15--0.00%
ONEGLOBAL
One Global Service Provider Limited
749 cr12.0x----14.1%-50.8%0.26%
GAUDIUMIVF
Gaudium IVF and Women Health Limited
724 cr28.7x4.4x16.1%20.4%0.0320.8%-0.00%
CHANDAN
Chandan Healthcare Limited
599 cr-3.5x-22.4%0.32--0.00%
PRAMODINI
Pramodini Medicare Limited
230 cr-2.0x--0.26--0.00%
INVICTA
Invicta Diagnostic Limited
97 cr-1.7x--0.02--0.00%
NIDAN
Nidan Laboratories and Healthcare Limited
18 cr14.8x0.3x-5.5%0.174.8%-8.4%0.00%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
+12.6
+12.5
-14.6
+4.4
+13.1
+13.1
+0.6
+0.2
-3.4
-6.8
+4.5
·
+37.0%
11m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-09-24POLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUND · bulkBUY25,45,719₹705.00₹179.47 Cr
2026-09-24EDORAS INVESTMENT HOLDINGS PTE LTD · bulkSELL8,42,109₹705.03₹59.37 Cr
2026-09-24MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulkBUY8,23,311₹705.24₹58.06 Cr
2026-09-24MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulkSELL8,15,776₹710.45₹57.96 Cr
2025-12-17POLAR CAPITAL FUNDS PLC-HEALTHCARE OPPORTUNITIES FUND · bulkBUY34,27,866₹481.77₹165.14 Cr
2025-12-17POONAWALLA VISION FUND I · bulkBUY6,10,000₹490.05₹29.89 Cr
2025-12-17MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulkSELL5,70,020₹483.30₹27.55 Cr
2025-12-17MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulkBUY5,70,020₹490.00₹27.93 Cr
Annual reports

The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.

Read enough? Test NEPHROPLUS. “Buy NEPHROPLUS when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free